InvestorsHub Logo
Followers 130
Posts 14996
Boards Moderated 1
Alias Born 06/04/2018

Re: None

Wednesday, 04/03/2019 11:40:37 AM

Wednesday, April 03, 2019 11:40:37 AM

Post# of 796
News: $IOVA Iovance Biotherapeutics to Present New Data from Ongoing Studies of Tumor-Infiltrating Lymphocyte (TIL) Therapy at 2019 American Society of Clinical Oncology (ASCO) Meeting

SAN CARLOS, Calif., April 03, 2019 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology, today announced that new interim data from Cohort 2 of the...

Got this from https://marketwirenews.com/news-releases/iovance-biotherapeutics-to-present-new-data-from-ongoing-studies-of-tumor-infiltrating-lymphocyte-til-therapy-at-2019-american-society-of-clinical-oncology-asco-meeting-7939064.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IOVA News